Martin Jönsson appointed new CEO of AlzeCure Pharma
AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders
AlzeCure is developing disease modifying and symptomatic first in class treatments for Alzheimer’s disease and other conditions characterized by cognitive dysfunction
Alzheimer’s disease is a deadly disorder which lacks effective treatments. The need for novel treatments is therefore urgent.